Karyopharm Therapeutics Inc (KPTI)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
Apr 26, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Total Return Level: 1.06 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 1.06 |
April 24, 2024 | 1.09 |
April 23, 2024 | 1.09 |
April 22, 2024 | 1.13 |
April 19, 2024 | 1.17 |
April 18, 2024 | 1.28 |
April 17, 2024 | 1.38 |
April 16, 2024 | 1.10 |
April 15, 2024 | 1.155 |
April 12, 2024 | 1.22 |
April 11, 2024 | 1.34 |
April 10, 2024 | 1.27 |
April 09, 2024 | 1.34 |
April 08, 2024 | 1.35 |
April 05, 2024 | 1.36 |
April 04, 2024 | 1.33 |
April 03, 2024 | 1.285 |
April 02, 2024 | 1.395 |
April 01, 2024 | 1.58 |
March 28, 2024 | 1.51 |
March 27, 2024 | 1.48 |
March 26, 2024 | 1.39 |
March 25, 2024 | 1.39 |
March 22, 2024 | 1.39 |
March 21, 2024 | 1.42 |
Date | Value |
---|---|
March 20, 2024 | 1.40 |
March 19, 2024 | 1.37 |
March 18, 2024 | 1.47 |
March 15, 2024 | 1.51 |
March 14, 2024 | 1.34 |
March 13, 2024 | 1.42 |
March 12, 2024 | 1.45 |
March 11, 2024 | 1.48 |
March 08, 2024 | 1.57 |
March 07, 2024 | 1.53 |
March 06, 2024 | 1.33 |
March 05, 2024 | 1.245 |
March 04, 2024 | 1.31 |
March 01, 2024 | 1.185 |
February 29, 2024 | 1.16 |
February 28, 2024 | 1.33 |
February 27, 2024 | 1.41 |
February 26, 2024 | 1.31 |
February 23, 2024 | 1.24 |
February 22, 2024 | 1.13 |
February 21, 2024 | 1.21 |
February 20, 2024 | 1.21 |
February 16, 2024 | 1.27 |
February 15, 2024 | 1.30 |
February 14, 2024 | 1.36 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.6758
Minimum
Nov 29 2023
27.72
Maximum
Mar 02 2020
8.445
Average
6.565
Median
Total Return Level Benchmarks
Geron Corp | 3.56 |
Arbutus Biopharma Corp | 2.72 |
Verastem Inc | 9.215 |
Actinium Pharmaceuticals Inc | 6.56 |
Chimerix Inc | 0.891 |